|
Section a2, a4 and a5: per regulation eu 2016/679 (general data protection regulation), patient identifiers were not collected or recorded and therefore are not available.Section d6a: if implanted, give date: not applicable, as there was no patient contact with the product.Section d6b: if explanted, give date: not applicable, as there was no patient contact with the product.(b)(6).Section h3: the intraocular lens (iol) was not returned for evaluation.Therefore, a failure analysis of the complaint device could not be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review and possible product return and evaluation, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
|
|
Section d9 - device available for evaluation? yes.Section d9 - date returned to manufacturer: 18-jun-2024.Section h3 - device evaluated by manufacturer? yes.Device evaluation: the product was returned to the manufacturing site for evaluation.Visual inspection was performed on the suspect product.The plunger rod was found partially advanced with the plunger rod tip and cartridge tip damaged.The tip damage was consistent with damage that occurred during shipping.The lens module was inspected and presented with no damage or viscoelastic residue indicating the plunger rod advanced properly.The device assembly and plunger rod assembly were inspected, and no issues were identified.No further evaluation was performed.The complaint issue "cosmetic issues" was not identified during product evaluation.The other observed issues during the product evaluation could not be confirmed to be related to the manufacturing or design process.Conclusion: based on the complaint investigation results, the product was released within specifications.No product deficiency or product malfunction could be identified.All pertinent information available to johnson and johnson surgical vision, inc.Has been submitted.
|